Evidence map›Paper›PMID 39132986›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Cell-surface Milieu Remodeling in Human Dendritic Cell Activation.

Namrata D Udeshi, Charles Xu, Zuzhi Jiang, Shihong Max Gao, Qian Yin, Wei Luo, Steven A Carr, Mark M Davis, Jiefu Li

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Namrata D UdeshiThe Broad Institute of MIT and Harvard, Cambridge, MA.ORCID 0000-0001-5312-1402
Charles XuThe Broad Institute of MIT and Harvard, Cambridge, MA.ORCID 0000-0002-7007-4035
Zuzhi JiangJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA.ORCID 0009-0009-1402-8235
Shihong Max GaoJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA.ORCID 0000-0003-3238-8348
Qian YinInstitute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA.
Wei LuoInstitute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0003-2826-1723
Steven A CarrThe Broad Institute of MIT and Harvard, Cambridge, MA.
Mark M DavisInstitute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0001-6868-657X
Jiefu LiJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA.

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
The effects of immune-age on immune-response and the molecular mechanisms which drive itP01AI153559 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2021 to 2025
$17.8M
ProteomicsP01CA206978 · NCI · DANA-FARBER CANCER INST · PI WU, CATHERINE JU-YING · 2016 to 2025
$17.0M
Center of Excellence for High Throughput Proteogenomic CharacterizationU24CA270823 · NCI · BROAD INSTITUTE, INC. · PI STEVEN A CARR, MICHAEL A GILLETTE · 2022 to 2026
$5.3M
Proteogenomic Predictors of Recurrence in Non-small Cell Lung CancerU01CA271402 · NCI · WASHINGTON UNIVERSITY · PI STEVEN A CARR, MICHAEL A GILLETTE · 2022 to 2026
$5.0M
The role of PTEN signaling in regulating germinal center B cell fate decisionR21AI175824 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI LUO, WEI · 2023 to 2024
$436k
Bill and Melinda Gates Foundation (GF)Broad Institute (BI) SPARC Award #800373Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)HHS | National Institutes of Health (NIH) AI175824HHS | National Institutes of Health (NIH) P01CA206978HHS | National Institutes of Health (NIH) U01CA271402HHS | National Institutes of Health (NIH) U19AI057229HHS | National Institutes of Health (NIH) U24CA270823Howard Hughes Medical InstituteHoward Hughes Medical Institute (HHMI)NCI NIH HHS P01 CA206978NCI NIH HHS U01 CA271402NCI NIH HHS U24 CA270823NIAID NIH HHS P01 AI153559NIAID NIH HHS R21 AI175824NIAID NIH HHS U19 AI057229Open Philanthropy Project
6 · The paper itself

Abstract

Dendritic cells (DCs) are specialized sentinel and APCs coordinating innate and adaptive immunity. Through proteins on their cell surface, DCs sense changes in the environment, internalize pathogens, present processed Ags, and communicate with other immune cells. By combining chemical labeling and quantitative mass spectrometry, we systematically profiled and compared the cell-surface proteomes of human primary conventional DCs (cDCs) in their resting and activated states. TLR activation by a lipopeptide globally reshaped the cell-surface proteome of cDCs, with >100 proteins upregulated or downregulated. By simultaneously elevating positive regulators and reducing inhibitory signals across multiple protein families, the remodeling creates a cell-surface milieu promoting immune responses. Still, cDCs maintain the stimulatory-to-inhibitory balance by leveraging a distinct set of inhibitory molecules. This analysis thus uncovers the molecular complexity and plasticity of the cDC cell surface and provides a roadmap for understanding cDC activation and signaling.

Indexed as

Dendritic CellsProteomeCell MembraneCells, CulturedHumansProteomicsSignal TransductionToll-Like ReceptorsProteomeToll-Like Receptors

Identifiers

PMID39132986
PMCPMC11408084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.